Local perfusion of corticosterone in the rat medial hypothalamus potentiates d-fenfluramine-induced elevations of extracellular 5-HT concentrations

Hormones and Behavior

Volumn 56, Issue 1, 2009, Pages 149-157

  Feng, Na ^a   Telefont, Martin ^a   Kelly, Kyle J ^b   Orchinik, Miles ^d   Forster, Gina L ^e   Renner, Kenneth J ^a,e   Lowry, Christopher A ^b,c  

^a W O Farber Center for Civic Leadership   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d ARIZONA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

5 hydroxytryptamine; Corticosterone; Dorsomedial hypothalamus; EMT; Extraneuronal monoamine transporter; OCT3; Organic cation transporter; Serotonin; Stress; Uptake 2

Indexed keywords

ALCOHOL; CARRIER PROTEIN; CORTICOSTERONE; DEXFENFLURAMINE; ORGANIC CATION TRANSPORTER 3; SEROTONIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CAGE; CONTROLLED STUDY; EXTRACELLULAR FLUID; HYPOTHALAMUS; HYPOTHESIS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STIMULUS RESPONSE; STRESS; VERTEBRATE;

ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; EXTRACELLULAR SPACE; FENFLURAMINE; GROOMING; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 65849305200     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.03.023     Document Type: Article

References (53)

1. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., and Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133 (2005) 983-997
2. Amphoux A., Vialou V., Drescher E., Bruss M., Mannoury La C.C., Rochat C., Millan M.J., Giros B., Bonisch H., and Gautron S. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50 (2006) 941-952
3. Aston-Jones G., Chen S., Zhu Y., and Oshinsky M.L. A neural circuit for circadian regulation of arousal. Nat. Neurosci. 4 (2001) 732-738
4. Baganz N.L., Horton R.E., Calderon A.S., Owens W.A., Munn J.L., Watts L.T., Koldzic-Zivanovic N., Jeske N.A., Koek W., Toney G.M., and Daws L.C. Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 18976-18981
5. Busch A.E., Quester S., Ulzheimer J.C., Gorboulev V., Akhoundova A., Waldegger S., Lang F., and Koepsell H. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett. 395 (1996) 153-156
6. Butler P.D., Weiss J.M., Stout J.C., and Nemeroff C.B. Corticotropin-releasing factor produces fear enhancing and behavioral activating effects following infusion into the locus coeruleus. Neuroscience 10 (1990) 176-183
7. Chanrion B., Mannoury La C.C., Bertaso F., Lerner-Natoli M., Freissmuth M., Millan M.J., Bockaert J., and Marin P. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 8119-8124
8. Culman J., Kvetnansky R., Torda T., and Murgas K. Serotonin concentration in individual hypothalamic nuclei of rats exposed to acute immobilization stress. Neuroscience 5 (1980) 1503-1506
9. Daws L.C. Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol. Ther. 121 (2009) 89-99
10. Di S., and Tasker J.G. Rapid synapse-specific regulation of hypothalamic magnocellular neurons by glucocorticoids. Prog. Brain Res. 170 (2008) 379-388
11. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23 (2003) 4850-4857
12. Di S., Maxson M.M., Franco A., and Tasker J.G. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J.Neurosci. 29 (2009) 393-401
13. DiMicco J.A., Samuels B.C., Zaretskaia M.V., and Zaretsky D.V. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacol. Biochem. Behav. 71 (2002) 469-480
14. Engel K., and Wang J. Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol. Pharmacol. 68 (2005) 1397-1407
15. Engel K., Zhou M., and Wang J. Identification and characterization of a novel monoamine transporter in the human brain. J. Biol. Chem. 279 (2004) 50042-50049
16. Farmer C.J., Isakson T.R., Coy D.J., and Renner K.J. In vivo evidence for progesterone dependent decreases in serotonin release in the hypothalamus and midbrain central grey: relation to the induction of lordosis. Brain Res. 711 (1996) 84-92
17. Feng N., Mo B., Johnson P.L., Orchinik M., Lowry C.A., and Renner K.J. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res. 1063 (2005) 69-76
18. Forster G.L., Feng N., Watt M.J., Korzan W.J., Mouw N.J., Summers C.H., and Renner K.J. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 141 (2006) 1047-1055
19. Gasser P.J., Lowry C.A., and Orchinik M. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J. Neurosci. 26 (2006) 8758-8766
20. Gasser P.J., Orchinik M., Raju I., and Lowry C.A. Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J. Comp. Neurol. 512 (2009) 529-555
21. Gasser, P. J., Lowry, C. A., and Orchinik, M. (in press). Rapid corticosteroid actions on behavior: mechanisms and implications. In D. W. Pfaff, A. P. Arnold, A. M. Etgen, S. E. Fahrbach, and R. T. Rubin (Eds.), Hormones, Brain and Behavior, second ed., pp. Academic Press, San Diego.
22. Graf M. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder. Neuropsychopharmacol. Hung. 8 (2006) 23-28
23. Graf M., Kantor S., Anheuer Z.E., Modos E.A., and Bagdy G. m-CPP-induced self-grooming is mediated by 5-HT2C receptors. Behav. Brain Res. 142 (2003) 175-179
24. Grubbs F.E. Procedures for Detecting outlying observations in samples. Technometrics 11 (1969) 1-21
25. Grundemann D., Koster S., Kiefer N., Breidert T., Engelhardt M., Spitzenberger F., Obermuller N., and Schomig E. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J. Biol. Chem. 273 (1998) 30915-30920
26. Hariri A.R., and Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10 (2006) 182-191
27. Herman J.P., Tasker J.G., Ziegler D.R., and Cullinan W.E. Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections. Pharmacol. Biochem. Behav. 71 (2002) 457-468
28. Hiasa M., Matsumoto T., Komatsu T., and Moriyama Y. Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations. Am. J. Physiol. Cell Physiol. 291 (2006) C678-C686
29. Koepsell H., Schmitt B.M., and Gorboulev V. Organic cation transporters. Rev. Physiol. Biochem. Pharmacol. 150 (2003) 36-90
30. Koepsell H., Lips K., and Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24 (2007) 1227-1251
31. Losada M.E.O. Corticosterone-induced acute changes on biogenic-amines' levels in some areas of the rat brain. Biogenic Amines 5 (1988) 239-247
32. Lowry, C. A. and Hale, M. W. (in press). Serotonin and the neurobiology of anxious states. In C. P. Mûller and B. L. Jacobs (Eds.), The Behavioural Neurobiology of Serotonin, pp. Elsevier, Amsterdam.
33. Lowry C.A., Burke K.A., Renner K.J., Moore F.L., and Orchinik M. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm. Behav. 39 (2001) 195-205
34. Lowry C.A., Plant A., Shanks N., Ingram C.D., and Lightman S.L. Anatomical and functional evidence for a stress-responsive, monoamine-accumulating area in the dorsomedial hypothalamus of adult rat brain. Horm. Behav. 43 (2003) 254-262
35. Martel F., Monteiro R., and Lemos C. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J. Pharmacol. Exp. Ther. 306 (2003) 355-362
36. Maswood S., Truitt W., Hotema M., Caldarola-Pastuszka M., and Uphouse L. Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Res. 831 (1999) 146-154
37. Moisan M.P., Seckl J.R., and Edwards C.R. 11 beta-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology 127 (1990) 1450-1455
38. Morsink M.C., van Gemert N.G., Steenbergen P.J., Joels M., De Kloet E.R., and Datson N.A. Rapid glucocorticoid effects on the expression of hippocampal neurotransmission-related genes. Brain Res. 1150 (2007) 14-20
39. Otsuka M., Matsumoto T., Morimoto R., Arioka S., Omote H., and Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17923-17928
40. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, Orlando, FL
41. Robson A.C., Leckie C.M., Seckl J.R., and Holmes M.C. 11 beta-Hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Mol. Brain Res. 61 (1998) 1-10
42. Roeling T.A., Veening J.G., Peters J.P., Vermelis M.E., and Nieuwenhuys R. Efferent connections of the hypothalamic "grooming area" in the rat. Neuroscience 56 (1993) 199-225
43. Rueter L.E., Fornal C.A., and Jacobs B.L. A critical review of 5-HT brain microdialysis and behavior. Rev. Neurosci. 8 (1997) 117-137
44. Sander L.D. Circadian influences on feeding-induced changes in ACTH and corticosterone secretion in rats. Regul. Pept. 41 (1992) 109-117
45. Sandi C., and Guaza C. Evidence for nitric oxide-mediated rapid locomotor effects of corticosterone in a novel environment. Ann. N.Y. Acad. Sci. 746 (1994) 398-399
46. Sandi C., Venero C., and Guaza C. Novelty-related rapid locomotor effects of corticosterone in rats. Eur. J. Neurosci. 8 (1996) 794-800
47. Sandi C., Venero C., and Guaza C. Nitric oxide synthesis inhibitors prevent rapid behavioral effects of corticosterone in rats. Neuroendocrinology 63 (1996) 446-453
48. Shekhar A., Katner J.S., Rusche W.P., Sajdyk T.J., and Simon J.R. Fear-potentiated startle elevates catecholamine levels in the dorsomedial hypothalamus of rats. Pharmacol. Biochem. Behav. 48 (1994) 525-529
49. Summers C.H., Risty G., Keane G., Hoffman C., Mahamodian M., and Renner K. Synergistic effects of corticosterone and progesterone on 5-HT release in the amygdala of estrogen primed rats. Society for Neuroscience Abstract 24 (1998) 1195
50. Tao R., Fray A., Aspley S., Brammer R., Heal D., and Auerbach S. Effects on serotonin in rat hypothalamus of d-fenfluramine, aminorex, phentermine and fluoxetine. Eur. J. Pharmacol. 445 (2002) 69-81
51. Vialou V., Balasse L., Callebert J., Launay J.M., Giros B., and Gautron S. Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J. Neurochem. 106 (2008) 1471-1482
52. Willner P., McGuirk J., Phillips G., and Muscat R. Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology (Berl.) 102 (1990) 273-277
53. Zhou M., Engel K., and Wang J. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem. Pharmacol. 73 (2007) 147-154